| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
AAAS
|
achalasia, adrenocortical insufficiency, alacrimia
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACD
|
adrenocortical dysplasia homolog (mouse)
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADAMTS12
|
ADAM metallopeptidase with thrombospondin type 1 motif, 12
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS7
|
ADAM metallopeptidase with thrombospondin type 1 motif, 7
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AGA
|
aspartylglucosaminidase
|
|
AGRN
|
agrin
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALPI
|
alkaline phosphatase, intestinal
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMH
|
anti-Mullerian hormone
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANKRD12
|
ankyrin repeat domain 12
|
|
AOC1
|
amine oxidase, copper containing 1
|
|
APC
|
adenomatous polyposis coli
|
|
APLN
|
apelin
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOE
|
apolipoprotein E
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARRB1
|
arrestin, beta 1
|
|
ARSA
|
arylsulfatase A
|
|
ATAD3A
|
ATPase family, AAA domain containing 3A
|
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAG6
|
BCL2-associated athanogene 6
|
|
BCAP31
|
B-cell receptor-associated protein 31
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
C12ORF65
|
chromosome 12 open reading frame 65
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1
|
|
C5
|
complement component 5
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1D
|
calcium channel, voltage-dependent, L type, alpha 1D subunit
|
|
CACNA1E
|
calcium channel, voltage-dependent, R type, alpha 1E subunit
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALR
|
calreticulin
|
|
CANX
|
calnexin
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCNT1
|
cyclin T1
|
|
CCP110
|
centriolar coiled coil protein 110kDa
|
|
CCR8
|
chemokine (C-C motif) receptor 8
|
|
CCRL2
|
chemokine (C-C motif) receptor-like 2
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CDC37
|
cell division cycle 37
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CENPA
|
centromere protein A
|
|
CENPH
|
centromere protein H
|
|
CENPJ
|
centromere protein J
|
|
CFH
|
complement factor H
|
|
CHCHD7
|
coiled-coil-helix-coiled-coil-helix domain containing 7
|
|
CHD1
|
chromodomain helicase DNA binding protein 1
|
|
CHD1L
|
chromodomain helicase DNA binding protein 1-like
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CLASP1
|
cytoplasmic linker associated protein 1
|
|
CLIP1
|
CAP-GLY domain containing linker protein 1
|
|
COL17A1
|
collagen, type XVII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL23A1
|
collagen, type XXIII, alpha 1
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL6A3
|
collagen, type VI, alpha 3
|
|
COPS5
|
COP9 signalosome subunit 5
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CTF1
|
cardiotrophin 1
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYTIP
|
cytohesin 1 interacting protein
|
|
DAO
|
D-amino-acid oxidase
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DEPDC5
|
DEP domain containing 5
|
|
DFNB59
|
deafness, autosomal recessive 59
|
|
DLX2
|
distal-less homeobox 2
|
|
DMD
|
dystrophin
|
|
DNAJA2
|
DnaJ (Hsp40) homolog, subfamily A, member 2
|
|
DNASE1L1
|
deoxyribonuclease I-like 1
|
|
DNASE1L2
|
deoxyribonuclease I-like 2
|
|
DNASE1L3
|
deoxyribonuclease I-like 3
|
|
DNTT
|
DNA nucleotidylexotransferase
|
|
DOCK8
|
dedicator of cytokinesis 8
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DPYS
|
dihydropyrimidinase
|
|
DYSF
|
dysferlin
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF1AX
|
eukaryotic translation initiation factor 1A, X-linked
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ENG
|
endoglin
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
EXOSC9
|
exosome component 9
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FAM134B
|
family with sequence similarity 134, member B
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FANCG
|
Fanconi anemia, complementation group G
|
|
FECH
|
ferrochelatase
|
|
FFAR1
|
free fatty acid receptor 1
|
|
FGA
|
fibrinogen alpha chain
|
|
FGF21
|
fibroblast growth factor 21
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FNDC5
|
fibronectin type III domain containing 5
|
|
FOXP3
|
forkhead box P3
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTO
|
fat mass and obesity associated
|
|
G6PC2
|
glucose-6-phosphatase, catalytic, 2
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GABRA4
|
gamma-aminobutyric acid (GABA) A receptor, alpha 4
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GDF15
|
growth differentiation factor 15
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLUL
|
glutamate-ammonia ligase
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GOLGA4
|
golgin A4
|
|
GPN1
|
GPN-loop GTPase 1
|
|
GSG2
|
germ cell associated 2 (haspin)
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HECTD4
|
HECT domain containing E3 ubiquitin protein ligase 4
|
|
HIRA
|
histone cell cycle regulator
|
|
HK1
|
hexokinase 1
|
|
HK2
|
hexokinase 2
|
|
HK3
|
hexokinase 3 (white cell)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HMGB1
|
high mobility group box 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HOTAIR
|
HOX transcript antisense RNA
|
|
HOXC4
|
homeobox C4
|
|
HSP90AA2P
|
heat shock protein 90kDa alpha (cytosolic), class A member 2, pseudogene
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR7
|
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDUA
|
iduronidase, alpha-L-
|
|
IFI27
|
interferon, alpha-inducible protein 27
|
|
IFI35
|
interferon-induced protein 35
|
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1)
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IGK
|
immunoglobulin kappa locus
|
|
IGSF8
|
immunoglobulin superfamily, member 8
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL10
|
interleukin 10
|
|
IL17A
|
interleukin 17A
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL27
|
interleukin 27
|
|
IL32
|
interleukin 32
|
|
IL33
|
interleukin 33
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
INHBA
|
inhibin, beta A
|
|
INS
|
insulin
|
|
IPO5
|
importin 5
|
|
IRF6
|
interferon regulatory factor 6
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
JAK1
|
Janus kinase 1
|
|
JAK3
|
Janus kinase 3
|
|
JAM3
|
junctional adhesion molecule 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDR
|
kinase insert domain receptor
|
|
KIR2DL5A
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KRT10
|
keratin 10, type I
|
|
KRTCAP2
|
keratinocyte associated protein 2
|
|
LARP1
|
La ribonucleoprotein domain family, member 1
|
|
LARP6
|
La ribonucleoprotein domain family, member 6
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LDLRAP1
|
low density lipoprotein receptor adaptor protein 1
|
|
LEP
|
leptin
|
|
LGALS13
|
lectin, galactoside-binding, soluble, 13
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LOX
|
lysyl oxidase
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPIN3
|
lipin 3
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LYL1
|
lymphoblastic leukemia associated hematopoiesis regulator 1
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
LYST
|
lysosomal trafficking regulator
|
|
MACC1
|
metastasis associated in colon cancer 1
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCFD2
|
multiple coagulation factor deficiency 2
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MED1
|
mediator complex subunit 1
|
|
MEFV
|
Mediterranean fever
|
|
MID1
|
midline 1
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR143
|
microRNA 143
|
|
MIR192
|
microRNA 192
|
|
MIR194-1
|
microRNA 194-1
|
|
MIR215
|
microRNA 215
|
|
MIR31
|
microRNA 31
|
|
MIR451A
|
microRNA 451a
|
|
MIR506
|
microRNA 506
|
|
MIR96
|
microRNA 96
|
|
MIR98
|
microRNA 98
|
|
MLEC
|
malectin
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MPG
|
N-methylpurine-DNA glycosylase
|
|
MST1
|
macrophage stimulating 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTM1
|
myotubularin 1
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUTYH
|
mutY homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow
|
|
MYLK
|
myosin light chain kinase
|
|
MYO5B
|
myosin VB
|
|
NAT6
|
N-acetyltransferase 6 (GCN5-related)
|
|
ND1
|
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFX1
|
nuclear transcription factor, X-box binding 1
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NLRP12
|
NLR family, pyrin domain containing 12
|
|
NLRP6
|
NLR family, pyrin domain containing 6
|
|
NMI
|
N-myc (and STAT) interactor
|
|
NOP56
|
NOP56 ribonucleoprotein
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NT5C3A
|
5'-nucleotidase, cytosolic IIIA
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NUCB2
|
nucleobindin 2
|
|
NUDT15
|
nudix (nucleoside diphosphate linked moiety X)-type motif 15
|
|
NUP98
|
nucleoporin 98kDa
|
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa
|
|
OPA3
|
optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)
|
|
ORC2
|
origin recognition complex, subunit 2
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PAH
|
phenylalanine hydroxylase
|
|
PARK7
|
parkinson protein 7
|
|
PAX5
|
paired box 5
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD10
|
programmed cell death 10
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDSS1
|
prenyl (decaprenyl) diphosphate synthase, subunit 1
|
|
PDSS2
|
prenyl (decaprenyl) diphosphate synthase, subunit 2
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PEX19
|
peroxisomal biogenesis factor 19
|
|
PIAS3
|
protein inhibitor of activated STAT, 3
|
|
PIR
|
pirin (iron-binding nuclear protein)
|
|
PKP3
|
plakophilin 3
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLEK
|
pleckstrin
|
|
PML
|
promyelocytic leukemia
|
|
POLDIP3
|
polymerase (DNA-directed), delta interacting protein 3
|
|
POLRMT
|
polymerase (RNA) mitochondrial (DNA directed)
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCSH
|
protein kinase C substrate 80K-H
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROS1
|
protein S (alpha)
|
|
PRR11
|
proline rich 11
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
|
RAB1A
|
RAB1A, member RAS oncogene family
|
|
RAB34
|
RAB34, member RAS oncogene family
|
|
RAD17
|
RAD17 homolog (S. pombe)
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RAX
|
retina and anterior neural fold homeobox
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RCAN1
|
regulator of calcineurin 1
|
|
RET
|
ret proto-oncogene
|
|
RIC1
|
RAB6A GEF complex partner 1
|
|
RLBP1
|
retinaldehyde binding protein 1
|
|
RNF115
|
ring finger protein 115
|
|
RORA
|
RAR-related orphan receptor A
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPL13A
|
ribosomal protein L13a
|
|
RPL3
|
ribosomal protein L3
|
|
RPLP1
|
ribosomal protein, large, P1
|
|
RPLP2
|
ribosomal protein, large, P2
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RRM2B
|
ribonucleotide reductase M2 B (TP53 inducible)
|
|
RUVBL1
|
RuvB-like AAA ATPase 1
|
|
RUVBL2
|
RuvB-like AAA ATPase 2
|
|
RXRA
|
retinoid X receptor, alpha
|
|
S100B
|
S100 calcium binding protein B
|
|
SAAL1
|
serum amyloid A-like 1
|
|
SAV1
|
salvador family WW domain containing protein 1
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SETBP1
|
SET binding protein 1
|
|
SETD2
|
SET domain containing 2
|
|
SETX
|
senataxin
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SGSH
|
N-sulfoglucosamine sulfohydrolase
|
|
SHH
|
sonic hedgehog
|
|
SLAMF6
|
SLAM family member 6
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A2
|
solute carrier family 2 (facilitated glucose transporter), member 2
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6
|
|
SLC2A8
|
solute carrier family 2 (facilitated glucose transporter), member 8
|
|
SLC30A10
|
solute carrier family 30, member 10
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SP1
|
Sp1 transcription factor
|
|
SPA17P1
|
sperm autoantigenic protein 17 pseudogene 1
|
|
SPX
|
spexin hormone
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
|
SSRP1
|
structure specific recognition protein 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STC1
|
stanniocalcin 1
|
|
SUMO4
|
small ubiquitin-like modifier 4
|
|
SV2A
|
synaptic vesicle glycoprotein 2A
|
|
SYK
|
spleen tyrosine kinase
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TADA3
|
transcriptional adaptor 3
|
|
TDRG1
|
testis development related 1 (non-protein coding)
|
|
TERT
|
telomerase reverse transcriptase
|
|
TF
|
transferrin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
THPO
|
thrombopoietin
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TMEM106B
|
transmembrane protein 106B
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOR2A
|
torsin family 2, member A
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPO
|
thyroid peroxidase
|
|
TRAF3IP2
|
TRAF3 interacting protein 2
|
|
TRNT1
|
tRNA nucleotidyl transferase, CCA-adding, 1
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TTC36
|
tetratricopeptide repeat domain 36
|
|
TTK
|
TTK protein kinase
|
|
TTR
|
transthyretin
|
|
TUT1
|
terminal uridylyl transferase 1, U6 snRNA-specific
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UBE2Q2
|
ubiquitin-conjugating enzyme E2Q family member 2
|
|
UBIAD1
|
UbiA prenyltransferase domain containing 1
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
UNC13B
|
unc-13 homolog B (C. elegans)
|
|
UNC5D
|
unc-5 homolog D (C. elegans)
|
|
UPB1
|
ureidopropionase, beta
|
|
USP15
|
ubiquitin specific peptidase 15
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VNN1
|
vanin 1
|
|
VWF
|
von Willebrand factor
|
|
WFIKKN1
|
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1
|
|
WFIKKN2
|
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2
|
|
WT1
|
Wilms tumor 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
YBX1
|
Y box binding protein 1
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
YTHDC1
|
YTH domain containing 1
|
|
ZNF804A
|
zinc finger protein 804A
|
